drugset / Trial / NCT02284256

A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery

NCT02284256

Phase 3 Completed 150 enrolled Mallinckrodt
RandomizedSingle-groupSingle-blindTreatment

Summary

The primary objective of the study is to demonstrate the non-inferiority or superiority of Fibrocaps plus gelatin sponge compared to Tachosil when control of mild to moderate bleeding with conventional surgical techniques is ineffective or impractical.

Timeline

Start
2014-11
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic Topical
Comparator TachoSil Other / unclassified Topical

Indications

No indication recorded.